Primary murine fetal hemopoietic cells were transformed with a fusion protein consisting of the ligand-binding domain of the estrogen receptor and a carboxylterminally truncated c-Myb protein (ERMYB). The ERMYB-transformed hemopoietic cells exhibit an immature myeloid phenotype when grown in the presence of b-estradiol. Upon removal of b-estradiol, the ERMYB cells display increased adherence, decreased clonogenicity and dierentiate to cells exhibiting granulocyte or macrophage morphology. The expression of the c-myc, ckit, cdc2 and bcl-2 genes, which are putatively regulated by Myb, was investigated in ERMYB cells grown in the presence or absence of b-estradiol. Neither c-myc nor cdc2 expression was down-regulated after removal of bestradiol demonstrating that dierentiation is not a consequence of decreased transactivation of these genes by ERMYB. While bcl-2 expression was reduced by 50% in ERMYB cells grown in the absence of bestradiol, there was no increase in DNA laddering, suggesting that Myb was not protecting ERMYB cells from apoptosis. In contrast, a substantial (200-fold) decrease in c-kit mRNA level was observed following dierentiation of ERMYB cells, and c-kit mRNA could be partially re-induced by the re-addition of b-estradiol. Furthermore, a reporter construct containing the c-kit promoter was activated when cotransfected with a Myb expression vector, providing further evidence of a role for Myb in the regulation of c-kit.
Introduction
The murine c-myb gene encodes a transcription factor which has a critical role in hemopoiesis. c-myb mRNA levels are high in undierentiated hemopoietic cells and decrease following dierentiation, suggesting that Myb is important for the proliferation of immature hemopoietic cells (Gonda and Metcalf, 1984) . Consistent with this notion, both truncated and wild type Myb can transform murine myeloid cells both in vivo and in vitro (Ferrao et al., 1995; Macmillan and Gonda, 1994; Gonda et al., 1989a,b) . Furthermore, antisense c-myb oligonucleotides block the proliferation of leukemic and normal hemopoietic cells and conversely, overexpression of Myb blocks the induced dierentiation of erythroid and myeloid cells (Yanagisawa et al., 1991; Anfossi et al., 1989; Clarke et al., 1988) . Mice with a homozygous de®ciency of c-myb die during gestation and fail to develop a normal hemopoietic system, demonstrating that Myb is essential for hemopoietic cell development (Mucenski et al., 1991) .
Myb binds to and transactivates promoters containing a consensus recognition sequence T/CAACG/TG (Nakagoshi et al., 1990; Weston and Bishop, 1989; Nishina et al., 1989) . The amino terminal DNA binding domain of Myb, which is related to the helix-turn-helix motif, is essential for transactivation of promoters containing the Myb recognition sequence (Ogata et al., 1994) . Analysis of truncated Myb proteins led to the de®nition of two additional domains: a transactivation domain located between amino acid (aa) residues 241 ± 325 and a negative regulatory domain (NRD) situated at the C-terminus (aa 326 ± 500) Sakura et al., 1989) . Deletion or mutation of the NRD results in a higher level of transactivation and transformation by Myb (Hu et al., 1991; Kanei-Ishii et al., 1992) . A correlation between transactivation and transformation of murine hemopoietic cells has led to the notion that the target genes which Myb regulates are critical to the transforming process (Hu et al., 1991) .
Putative cellular targets of Myb transactivation include c-kit, CD34, mim-1, neutrophil elastase and CD13 aminopeptidase, all of which are expressed on immature hemopoietic cells (Oelgeschlager et al., 1996; Melotti and Calabretta, 1996; Shapiro, 1995; Melotti et al., 1994; Ness et al., 1993; Burk et al., 1993; Ratajczak et al., 1992) . Activation by Myb of T-lymphocyte speci®c genes such as CD4, T cell receptor d and lck tyrosine kinase and of genes which function in cell growth control such as cdc2 and c-myc has also been demonstrated (Hernandez-Munain and Krangel, 1995; McCracken et al., 1994; Cogswell et al., 1993; Ku et al., 1993; Siu et al., 1992; Nakagoshi et al., 1992; Evans et al., 1990) . The bcl-2 gene, which serves an antiapoptotic function in various cell types, has very recently been reported as a Myb target gene (Salomoni et al., 1997; Taylor et al., 1996; Frampton et al., 1996) . Other transcription factors can cooperate with Myb to achieve maximal levels of transcriptional activation (Oelgeschlager et al., 1996; Dai et al., 1996; Hernandez-Munain and Krangel, 1995; Shapiro, 1995; McCracken et al., 1994; Burk et al., 1993; Ness et al., 1993) , and thus may enhance transactivation of target genes and direct cellular speci®city.
Studies of putative Myb-regulated genes have relied predominantly upon the activation of arti®cial reporter gene constructs in cell lines transiently transfected with cmyb (Oelgeschlager et al., 1996; Shapiro, 1995; McCracken et al., 1994; Burk et al., 1993; Ness et al., 1993; Ku et al., 1993; Cogswell et al., 1993; Evans et al., 1990) . The expression of a conditionally active Myb protein in primary cells, however, would more closely mimic the situation in vivo and may allow the de®nition of the physiological targets of Myb which are important for myeloid cell proliferation and dierentiation. Conditionally active forms of a number of transcription factors have been constructed by fusion with a portion of the estrogen receptor containing the ligand binding domain (but not the DNA binding domain) (Lyon and Watson, 1995; Boehmelt et al., 1992; Burk and Klempnauer, 1991; Eilers et al., 1989) . Accordingly, we have developed a conditional system for transformation by Myb, by expressing a C-terminally truncated Myb protein fused to the estrogen binding domain of the human estrogen receptor in primary murine hemopoietic cells. Cells transformed by the estrogen receptor/Myb fusion protein (ERMYB) were dependent on b-estradiol for growth, and dierentiated to mature granulocytes and macrophages on withdrawal of b-estradiol. Thus, this system allowed us to investigate the regulation of putative Myb-transactivated genes in primary cells in which the only lesion is the presence of a transforming Myb protein. With this in mind, we examined the expression of four putative Myb-regulated genes ± cdc2, c-myc, c-kit and bcl-2 ± which could potentially mediate the proliferative eects of Myb on myeloid cells. c-kit encodes a transmembrane tyrosine kinase with a critical role in the growth of immature hemopoietic cells (reviewed in Galli et al., 1994) . cdc2 encodes a protein kinase that plays a pivotal role in cell cycle progression (van den Heuvel and Harlow, 1993; Lee and Nurse, 1987) . The c-Myc transcription factor is thought to be a major regulator of cell growth, dierentiation and apoptosis (reviewed in LuÈ scher and Eisenman, 1990; Evan et al., 1992) ; and the bcl-2 gene inhibits cell death in a variety of cell types (reviewed in Craig, 1995) . Our results do not support a role for Myb in the regulation of cdc2 or c-myc in myeloid cells. C-kit and bcl-2 expression levels, however, did correlate with activation of the ERMYB fusion protein.
Results

Construction of an estradiol-inducible myb retroviral vector
In order to construct a hemopoietic cell line which expressed a conditionally active Myb protein, the ligand binding domain of the estrogen receptor (ERLBD) was cloned into a retroviral vector RED(CT3Myb) which expresses a C-terminally truncated Myb protein (CT3Myb) (Hu et al., 1991) . The CT3Myb protein encodes the DNA binding domain and transactivation domains of Myb but lacks the negative regulatory domain and is one of the most potent transforming and transactivating forms of Myb Hu et al., 1991; Sakura et al., 1989) . The ERLBD was cloned in frame into the gag sequence located upstream of CT3Myb in RED(CT3Myb) to create RED(ERMYB) (Hu et al., 1991; Gonda et al., 1989a,b) (Figure 1a) . The structure of the RED(ERMYB) proviral DNA, the expected mRNA and protein products and a restriction enzyme map of the construct is shown in Figure 1 . A full length genomic mRNA and a spliced sub-genomic mRNA are produced by the RED series of retroviral vectors (Hu et al., 1991; Gonda et al., 1989a,b ) (see Figure 1b) . In addition to producing a full length genomic RNA of 4.7 kb, two sets of potential splice sites (SD1, SA1, SD2, SA2) in RED(ERMYB), generate a 3.4 kb subgenomic mRNA species. The RED(ERMYB) construct was designed to produce an ERMYB protein initiating at the ATG codon in the gag sequence (Figure 1a and b) . Thus, the ERMYB fusion protein would be expected to contain an additional 20 amino acids (aa) of gag sequence at the amino terminus.
The fusion of the ERLBD to Myb should confer estrogen-dependent activation of Myb transcriptional activity. In order to examine the eect of estrogen on Figure 1 Structure of the RED(ERMYB) retroviral construct. The structure of the integrated proviral DNA is shown in (a). The coding portion contains the gag viral DNA (®lled box), into which the estrogen receptor ligand binding domain (ER) (open box) was cloned and also encodes a C-terminally truncated Myb protein (MYB) (not to scale). The integrated DNA is¯anked by the viral long terminal repeates (LTR). Protein translation initiates at the ATG codon shown in the gag sequence and is terminated at the premature stop codon (TGA) in the MYB sequence. The structure of the viral genomic and spliced mRNA products (upper) and ERMYB fusion protein (lower) are shown in (b) (not to scale). The use of the splice sites SD1, SA1 and SD2, SA2 remove 1.16 kb and 0.2 kb of sequence, respectively, generating a spliced RNA which encodes the ERMYB fusion protein. A schematic representation (not to scale) of the proviral RED(ERMYB) DNA showing the locations of restriction enzyme (RE) sites is shown in (c) (S, SacI; H, HindIII; E, EcoRI). The boxes above the (RE) map represent cDNA probes used to probe Southern blots and are derived from the c-myb (stippled) and ER cDNA (open), respectively ] was used as a non-inducible control. Transfection of pUC13-RSV(v-myb) resulted in a 16-fold induction of CAT activity compared to pUC13-RSV alone (Table 1) . As expected, the addition of b-estradiol had no eect on the levels of CAT activity in the presence of pUC13-RSV(v-myb). The addition of b-estradiol to Balb/c 3T3 cells transfected with the p8MybbCAT reporter plasmid and RED(ERMYB), however, resulted in a 60-fold induction of reporter gene activity (Table 1) . Importantly, the levels of reporter gene activity in the absence of b-estradiol were similar to that obtained with pUC13-RSV alone, indicating that there was negligible transcriptional activity from ERMYB in the absence of b-estradiol induction.
Generation of ERMYB transformed cells
ERMYB transformed hemopoietic cells were generated by co-cultivation of RED(ERMYB) transfected C2 packaging cells with murine fetal liver cells as described previously (Gonda et al., 1989a (Gonda et al., , 1993 Hu et al., 1991 (Figures 1c and 2a) . These fragments were absent from the control DNA, indicating that they were derived from the integrated RED(ERMYB) vector (Figure 2a ). In addition, a 3 kb EcoRI/SacI DNA fragment from ERMYB cells hybridized to a cDNA probe derived from the ligand binding domain of the human estrogen receptor and was absent in control DNA (Figures 1c and 2a) . These results indicate that the coding portion of the RED(ERMYB) vector had incorporated intact into the genome of the transformed cells.
In order to determine the sizes of the genomic and spliced RNA species produced by the RED(ERMYB) vector and to ascertain whether b-estradiol in¯uenced the expression of RED(ERMYB), poly(A) + mRNA was prepared from ERMYB transformed cells grown in the presence or absence of b-estradiol. Two transcripts of 4.7 kb and 3.4 kb were observed when Northern blots prepared using poly(A) + mRNA from ERMYB cells were probed with the ligand binding domain of the human estrogen receptor (Figure 2b ). These transcripts corresponded to the sizes expected for the genomic mRNA and sub-genomic spliced mRNA, respectively (Figure 1b) , and also hybridized to a c-myb cDNA probe (data not shown). The smaller species is unlikely to represent the 3.6 kb endogenous c-myb mRNA since other Myb-transformed hemopoietic cells do not produce detectable levels of this message (Hu et al., 1991; Lipsick, 1987) , and the ratio of the 4.7 kb and 3.4 kb transcripts was the same when Northern blots were probed with either the 5' c-myb cDNA probe or the ERLBD cDNA probe.
To verify expression of the ERMYB fusion protein, Western blots of whole cell lysates from ERMYB transformed cells were probed with a monoclonal antibody (5.1) which recognizes the amino terminal region of murine Myb (Ramsay et al., 1989) . This antibody detected a 35 kd protein, as expected (Hu et al., 1991) , in murine hemopoietic cells transformed by the RED(CT3Myb) retroviral vector (Figure 2c ). The ERLBD, which is fused to CT3Myb to generate the ERMYB fusion protein, encodes 287 amino acids and thus the presence of a protein of 65 kd in the ERMYB transformed cells (but not in the CT3Myb transformed cells) was consistent with the predicted molecular weight of the ERMYB fusion protein. The additional band present in lysates from both the CT3Myb and ERMYB cells was also detected in cells not expressing Myb (not shown) and was, therefore, probably due to a non-speci®cally cross-reacting protein. These results con®rmed that the ERMYB transformed murine hemopoietic cells were expressing ERMYB mRNA and protein derived from the RED(ERMYB) retroviral vector. (Gonda et al., 1989a; Ramsay et al., 1989) . Proteins of 65 kd and 35 kd were observed (shown at right) corresponding to the predicted sizes of the ERMYB fusion protein and the CT3MYB protein, respectively estradiol consisted of small, rounded, highly refractile cells typical of immature hemapoietic cells. In contrast, in the absence of b-estradiol, no colonies and only 23 clusters were observed. Those cells which grew in the absence of b-estradiol were elongated with numerous cytoplasmic processes (not shown) which are features of more dierentiated myeloid cells. These experiments demonstrated that the ERMYB transformed cells were dependent on b-estradiol for proliferation under clonal assay conditions.
Staining of cytospin preparations from ERMYB cells grown in liquid culture in the presence of bestradiol showed that they resembled immature myeloid cells typical of other hemopoietic cells transformed by C-terminally truncated Myb (Ferrao et al., 1995; Gonda et al., 1989a,b) . The cells were relatively small and rounded with a high nuclear/ cytoplasmic ratio ( Figure 4a ). After 7 h of b-estradiol deprivation, an increase in cell size and cytoplasmic granularity and a decrease in the nuclear/cytoplasmic ratio was noted ( Figure 4b ). Following 24 h of bestradiol deprivation, the nuclear/cytoplasmic ratio had decreased substantially and cells characteristic of various stages of neutrophil maturation, including myelocytes, metamyelocytes, band neutrophils and mature segmented neutrophils, were observed ( Figure  4c ). Cells in the early stages of macrophage development were also present ( Figure 4c ). By 48 h of b-estradiol withdrawal, the ERMYB cells comprised predominantly mature macrophages and mature segmented neutrophils (Figure 4d ). After 3 ± 6 days of b-estradiol deprivation, the majority of the cells resembled mature macrophages and very few (510%) mature segmented neutrophils were present (Figure 4e, f) . Taken together, these observations show that ERMYB cultures were dependent on bestradiol to maintain an immature myeloid phenotype and developed characteristics typical of maturing myeloid cells, predominantly of the neutrophil and monocyte/macrophage lineages following b-estradiol deprivation.
Like other murine Myb transformed cells (Gonda et al., 1989a (Gonda et al., ,b, 1993 , ERMYB cells expressed cell surface markers indicative of the granulocyte/macrophage lineage in that they expressed Mac 1, Mac 3 and F4/ 80 when grown with or without b-estradiol (data not shown). We therefore decided to examine expression of a marker of early hemopoietic cells, on ERMYB cells. We have shown previously that Thy-1, a marker expressed on hemopoietic stem and progenitor cells, is expressed on Myb-transformed cells, presumably re¯ecting an early myeloid phenotype (Gonda et al., 1993) . Thy-1 was expressed on 25 ± 30% of ERMYB cells in the presence of b-estradiol, in accordance with these results (data not shown). Thy-1 was not expressed, however, on ERMYB cells grown in the absence of b-estradiol for 48 h (data not shown), re¯ecting the more dierentiated state of the latter cells.
We next sought to determine whether enzymes speci®c for the granulocyte and macrophage lineages were expressed on ERMYB cells. Cells were stained for naphthol-AS-D-acetate esterase (neutrophil esterase), an enzyme speci®c for the neutrophil lineage and anapthylacetate esterase (macrophage esterase) which is expressed in macrophages. The proportion of cells expressing NE alone was signi®cantly higher in cells grown without b-estradiol for 1 day compared to cells grown in the presence of b-estradiol and decreased thereafter ( Table 2 ). The decrease in cells staining positive for NE alone after 2 days of b-estradiol withdrawal presumably re¯ects the short lifespan of mature neutrophils and is in agreement with the morphological data. In contrast, the proportion of cells expressing ME alone increased signi®cantly from 1 ± 3% to 80% following withdrawal of b-estradiol for 2 days and remained high up to 6 days ( Table 2 ). In parallel, the intensity of ME staining also increased markedly (data not shown). Presumably, the dierent Are ERMYB cells reversibly dierentiated in the absence of b-estradiol?
Clearly, the absence of b-estradiol from the culture medium resulted in the dierentiation of ERMYB cells. In order to determine if the dierentiation process was reversible, the cells were deprived of b-estradiol for 3 ± 7 days, following which b-estradiol was re-added to the culture medium. The cells failed to revert to an immature, transformed phenotype. b-estradiol deprivation for up to 24 h, however, lead to the maintenance of at least some immature cells following the readdition of b-estradiol (data not shown). Next, we studied the clonogenic potential of ERMYB cells from which b-estradiol was removed and then re-added in order to examine the extent and kinetics of the loss of clonogenicity. ERMYB cells, grown in the presence or absence of b-estradiol in liquid culture for various periods of time, were plated in methylcellulose in the presence of b-estradiol (methylcellulose/1 mM b-estradiol), and the number of colonies/clusters were counted after 7 and 14 days ( Figure 5) . Surprisingly, the number of colonies formed by ERMYB cells grown continuously in b-estradiol was not constant during the time course. The initial increase in colony number may re¯ect densitydependent eects (due to a putative autocrine factor) on the clonogenicity of Myb-transformed cells, as have been described elsewhere (Macmillan and Gonda, 1994) . The subsequent decrease in clonogenicity observed following 24 h of liquid culture in the presence of b-estradiol may be a consequence of the higher proportion of mature cells resulting from the spontaneous dierentiation of ERMYB cells observed at higher cell densities (data not shown).
The ability of b-estradiol-deprived ERMYB cells to form colonies/clusters in methylcellulose/1 mM bestradiol, however, decreased rapidly with time. After 24 h of b-estradiol deprivation, colonly formation was substantially reduced while by 72 h, only occasional colonies/clusters were observed ( Figure 5 ). The colonies formed by b-estradiol-deprived ERMYB cells developed more dierentiated characteristics as the period of b-estradiol deprivation was lengthened. Thus, the ability of the cells to form colonies is probably due to the maintenance of proliferative capacity during early stages of dierentiation rather than reversion of dierentiated cells. We conclude, therefore, that following 72 h of b-estradiol deprivation, once complete dierentiation has taken place as assessed by morphological criteria, the ERMYB cells undergo irreversible processes which prevent the re-acquisition of properties of immature hemopoietic cells despite the re-activation of Myb.
Regulation of putative Myb-target genes in ERMYB cells
We have shown that transactivation by ERMYB is dependent on b-estradiol and that ERMYB cells dierentiated upon removal of b-estradiol into mature neutrophils and macrophages. Next, we wanted to examine whether the expression of several putative Myb-regulated genes did, in fact, correlate with Myb activity and if they were regulated during the dierentiation process. We concentrated on some of those putative Myb-regulated genes which are typically expressed by myeloid cells. Poly(A) + mRNA was isolated from ERMYB cells grown with or without b-estradiol for 6, 24 or 48 h. Although we had demonstrated that fully dierentiated ERMYB cells do not revert to an immature morphology following the readdition of b-estradiol, it was possible that some Myb-regulated genes might be transactivated upon readdition of b-estradiol to partially dierentiated cells. The percentage of cells staining positive for NE or ME is shown Thus, we also examined poly(A) + mRNA from cells deprived of b-estradiol for 24 h and to which bestradiol was subsequently re-added for 6 or 48 h. Northern blots of these mRNA samples probed with cdc2, c-myc and c-kit are shown in Figure 6 . The amount of mRNA at each timepoint was measured relative to the signal generated using a GAPDH cDNA probe (Figure 6 ).
cdc2 levels were relatively constant in cells grown up to 48 h without b-estradiol, and showed no increase in 24 h b-estradiol deprived cells to which b-estradiol was re-added ( Figure 6 ). These data show that activity of the ERMYB protein does not have a signi®cant eect on cdc2 mRNA levels in ERMYB cells and that the downregulation of cdc2 is not responsible for the loss of proliferative capacity observed on withdrawal of bestradiol from ERMYB cells. We next examined c-myc expression in ERMYB cells grown in the presence or absence of b-estradiol (Figure 6 ). While some variation in c-myc mRNA levels was observed over the time course of b-estradiol withdrawal, there was no correlation observed between c-myc mRNA expression and the presence of b-estradiol. This experiment shows that cmyc mRNA levels are not signi®cantly aected by ERMYB activity and that a decrease in c-myc mRNA expression is not associated with the earlier stages of granulocyte/macrophage dierentiation of ERMYB cells (see Discussion). Expression of c-kit mRNA was similar in ERMYB cells grown in the presence or absence of b-estradiol for 6 h. Following 24 h of bestradiol deprivation, however, a dramatic decrease (200-fold) in the expression of c-kit mRNA was observed (Figure 6 ). c-kit mRNA expression remained low in ERMYB cells grown for 48 h without b-estradiol. Furthermore, c-kit mRNA levels increased 18-fold in 24 h b-estradiol deprived ERMYB cells to which bestradiol was re-added for 48 h. These data support a role for Myb in the regulation of c-kit expression.
A possible explanation for the decrease in the expression of c-kit mRNA upon inactivation of Myb activity in ERMYB cells is that the expression levels of c-kit are related to the dierentiation state of the cells and are indirectly regulated by Myb activity. The low level of c-kit expression observed in dierentiated hemopoietic cells is consistent with this notion (Andre et al., 1989) . We wanted to determine, therefore, if the c-kit promoter was regulated by Myb. For this purpose, a reporter plasmid containing the mouse ckit promotor linked to the CAT gene (pkit-CAT02N; Figure 7a ) was co-transfected with a vector expressing wild-type or mutant c-Myb proteins (Sakura et al., 1989) lacking either the DNA-binding domain (DDB) or the transactivation domain (DTA) into CV-1 cells. DDB and DTA mutant c-Myb proteins did not activate the c-kit reporter gene construct. In contrast, c-Myb activated c-kit reporter gene transcription 12-fold relative to cells transfected with the empty control plasmid (Figure 7b) . Examination of the sequence of the c-kit promoter between 72710 and +1 revealed six potential Myb binding sites ( (Deng et al., 1996) ; Figure  7a ). These data suggest that Myb is capable of transactivating the c-kit promoter directly, lending further support for a role of Myb in the regulation of c-kit expression.
Apoptosis in ERMYB cells
Myb up-regulates bcl-2 and suppresses apoptosis in at least some myeloid and T cells (Salomoni et al., 1997; Taylor et al., 1996; Frampton et al., 1996) . To establish whether ERMYB cells were undergoing apoptosis upon inactivation of Myb, the viability of ERMYB cells was examined following b-estradiol withdrawal. Viability was rapidly reduced in the absence of GM-CSF in a bestradiol-independent manner demonstrating the growth factor dependence of the ERMYB cell line, as expected (Figure 8a ). When ERMYB cells were grown in GM-CSF in medium lacking b-estradiol a slight decrease in viability (10 ± 15%) was also observed.
In order to determine if apoptosis accompanied the decrease in viability observed upon inactivation of Myb, DNA laddering was examined in ERMYB cells grown with or without b-estradiol. DNA laddering was + mRNA from ERMYB cells grown with (+) or without (7) b-estradiol for 0, 6, 24 or 48 h (lanes 1 ± 7) and from cells grown without b-estradiol for 24 h and to which b-estradiol was subsequently re-added for 6 or 48 h (lanes 8, 9) is shown. Northern blots were probed with cdc2, c-myc or c-kit cDNA probes (upper panels) and re-probed with GAPDH (lower panels) in order to quantitate expression levels. The mRNA levels relative to GAPDH levels are shown below each pair of Northern blots Differentiation following inactivation of ER-Myb A Hogg et al observed in ERMYB cells grown without GM-CSF (Figure 8b ). In the presence of GM-CSF, however, no signi®cant DNA laddering was observed either in the presence or absence of b-estradiol (Figure 8b ). We next examined if decreased bcl-2 expression accompanied the reduced viability of ERMYB cells. The levels of bcl-2 appear to be very low in ERMYB cells, since at least 4 mg poly(A) + RNA were required for its detection on Northern blots (unpublished observations). A 50% reduction was observed, however, in ERMYB cells grown without b-estradiol for 24 h. We conclude that decreased bcl-2 expression correlates, to a degree, with loss of Myb activity but not with an increase in apoptosis, as measured by DNA laddering. (Macmillan and Gonda, 1994; Gonda et al., 1993) . We have used a Myb/estrogen receptor fusion protein (ERMYB) in order to conditionally transform primary murine hemopoietic cells and to investigate the regulation of Myb target genes which may mediate the ability of Myb to transform hemopoietic cells. Although Myb/ER fusion proteins have been expressed in cell lines (e.g. Lyon and Watson, 1995; Burk and Klempnauer, 1991) , this is the ®rst report (to our knowledge) of the transformation of mammalian primary cells using a Myb/ER fusion protein. (Very recently, Lipsick and colleagues (Engelke et al., 1997) have reported transformation of avian yolk sac cells by a v-Myb-ER fusion). We have shown that if this conditionally active form of Myb is inactivated, a process of dierentiation along the macrophage/ neutrophil pathway is observed, proliferation is inhibited and the expression of the early cell surface marker, Thy-1, is ablated. That the transformed phenotype is mediated by Myb and not estrogen is demonstrated by the lack of estrogen receptors on Myb transformed cells (data not shown), the lack of any discernible eect of b-estradiol on cells transformed by CT3Myb (data not shown) and the consistency of the ERMYB phenotype in the presence of b-estradiol with Myb transformed cells described previously (Gonda et al., 1989a (Gonda et al., ,b, 1993 .
The re-addition of b-estradiol to ERMYB cells induced to dierentiate by b-estradiol withdrawal resulted in full retention of their proliferative capacity, as assessed by clonogenicity in methylcellulose, only when the period of b-estradiol withdrawal was no longer than 4 h. After this time, the ability of the cells to regain their proliferative capacity was progresssively lost over the next 72 h. The ERMYB cells which continued to proliferate when b-estradiol was re-added presumably represent a population which had undergone only partial dierentiation rather than indicating a reversion of dierentiated cells. This premise is based on the lack of reversion once the entire population had undergone complete differentiation as assessed by the morphology of cells in methylcellulose, Giemsa staining, and the expression patterns of granulocyte and macrophage-speci®c enzymes. The latter criteria demonstrate that 1 ± 6 days were required for fully mature neutrophils and macrophages to develop, implying that some less mature cells were present at earlier times.
In contrast, avian hemopoietic cells transformed by an E26 mutant encoding a temperature sensitive MybEts protein (E26ts) have a myeloblastic phenotype at 378C and dierentiate to mature macrophages after shifting to 428C (Beug et al., 1987) . Unlike the murine ERMYB cells described here, dierentiated E26ts cells can revert to immature cells after returning to 378C. They are irreversibly dierentiated, however, if kept at 428C for longer than 4 ± 8 days. Furthermore, AMV v-myb can transform mature avian macrophages, although this ability decreases as the cells become more terminally dierentiated, and may be due to increased resistance to transformation as they withdraw from the cell cycle (Durban and Boettiger, 1981) . The irreversibility of granulocyte/macrophage differentiation following withdrawal of b-estradiol from ERMYB cells may re¯ect dierences between avian and murine myeloid cells. For example, it is possible that dierent cooperating transcription factors are expressed in murine as compared to avian cells, and that the absence of one such factor prevents the reactivation of Myb-dependent genes necessary for the reversion of dierentiated murine ERMYB cells. Alternatively, very high levels of Myb expression may also be necessary in order to re-transform ERMYB cells.
The correlation between transactivation and transformation by Myb (Lane et al., 1990; Kanei-Ishii et al., 1992; Hu et al., 1991) suggests that the ability of Myb to transform hemopoietic cells is dependent on the transactivation of genes critical for this process. We have investigated the regulation of several putative Myb regulated genes in the ERMYB transformed cells and have found that cdc2 and c-myc mRNA levels do not correlate with activation of Myb. Endogenous Myb is not detected in the ERMYB cells (data not shown), thus excluding the possibility that endogenous Myb protein could mask the eect of inactivating the fusion protein. Furthermore, we ®nd that the mRNA levels of two other putative Myb regulated genes (c-kit and bcl-2) do correlate with Myb activity.
It has been postulated that the regulation of hemopoietic cell proliferation by Myb is related to cell cycle control. In support of this notion, c-myb antisense oligonucleotides block T-lymphocytes at the G1/S transition . c-myb and cdc2 mRNAs are induced when quiescent T lymphocytes are stimulated with mitogens and can be blocked by c-myb antisense oligonucleotides, suggesting that cdc2 and cmyb regulation might be linked (Furukawa et al., 1990) . In fact, Myb has been shown to bind to and transactivate the cdc2 promoter in ®broblasts (Ku et al., 1993) . However, no decrease in cdc2 expression was observed in ERMYB cells induced to dierentiate up to 48 h following removal of b-estradiol, by which time maturing granulocytes and macrophages were evident and colony formation in methylcellulose was markedly reduced. It is possible that a decrease in cdc2 levels occurs at later stages of dierentiation but clearly, regulation of cdc2 is not responsible for the early stages of growth inhibition and dierentiation observed upon inactivation of Myb.
c-myc expression stimulates cell proliferation and exerts a negative eect on terminal dierentiation (Holt et al., 1988; Homan Liebermann and Liebermann, 1991; Kume et al., 1988; Eilers et al., 1991; reviewed in LuÈ scher and Eisenman, 1990) . Because Myb can also inhibit the dierentiation of hemopoietic cells (Selvakumaran et al., 1994; Todokoro et al., 1988; Yanagisawa et al., 1991; Clarke et al., 1988) , it has been postulated that the eect of Myb on cellular proliferation may be due to the regulation of c-myc transcription. Indeed, transactivation by Myb of the cmyc promoter (Evans et al., 1990; Nakagoshi et al., 1992; Zobel et al., 1992) and in one case, endogenous c-myc (Evans et al., 1990) has been reported. Unlike the studies of the regulation of c-myc by Myb reported previously, our studies address the question in primary myeloid cells in which the only lesion introduced is the expression of the ERMYB fusion protein. We demonstrate that c-myc mRNA levels are not downregulated upon dierentiation of ERMYB cells after 48 h of b-estradiol withdrawal (although it is likely that c-myc levels are reduced in more terminally dierentiated, non-proliferating cells, as seen in other systems; e.g. see review by LuÈ scher and Eisenman, (1990)). Importantly, these results imply that c-Myc is not mediating the proliferative or dierentiationblocking eects of Myb in these cells. Consistent with our results, it has been shown that down-regulation of c-myc expression is not required for Epo-induced dierentiation of erythroleukemia cells (Todokoro et al., 1988) . The ®nding that Myb blocks myeloid cell dierentiation at an earlier stage than c-Myc is further evidence that the eect of Myb is not mediated by cmyc regulation (Selvakumaran et al., 1994) .
It may be signi®cant that the reports of transactivation of the chromosomal c-myc (Evans et al., 1990) and cdc2 (Furukawa et al., 1990 ) genes both pertain to T lymphocytes. The regulation of c-myb in mature lymphoid cells is cell cycle-speci®c, in contrast to earlier T cells (Catron et al., 1992; reviewed in Thompson and Ramsay, 1995) . Thus c-myb may play a somewhat dierent role in more mature cells, e.g. in mitogen-induced cell cycle progression, and may therefore act on dierent target genes.
The regulation of apoptosis and bcl-2 expression by Myb has recently been reported (Salomoni et al., 1997; Taylor et al., 1996; Frampton et al., 1996) . We show a continuing loss of viability and increased apoptosis in ERMYB cells when deprived of GM-CSF. In contrast, inactivation of Myb in the presence of GM-CSF results in a small decrease in viability and no detectable apoptosis. Our results do support the above-mentioned reports of regulation of bcl-2 expression by Myb, although the contribution of Myb to total bcl-2 expression appears much less in ERMYB cells. However, the levels of bcl-2 expression are very low in the ERMYB cells, and are presumably not sucient to prevent the cell death observed upon growth factor withdrawal. The anti-apoptotic eects of Myb appear to depend on the apoptotic stimulus and may also be cell type-speci®c (Salomoni et al., 1997; Frampton et al., 1996) . Thus, we conclude that mechanisms other than the protection of cells from apoptosis are responsible for the transformation of murine myeloid cells by Myb.
We show that inactivation of a Myb/estrogen receptor fusion protein in ERMYB cells precedes an almost complete loss of c-kit mRNA expression. This decrease in c-kit mRNA expression occurs between 6 and 24 h following inactivation of Myb. Our results demonstrating transactivation of a c-kit reporter construct by Myb but not by mutant Myb proteins lacking the DNA binding or transactivation domains are consistent with direct regulation of the c-kit gene, as we show that Myb transactivates an 8.8 kb region of the c-kit promoter which contains six potential Mybbinding sites. These data support and extend other studies documenting a correlation between Myb and cKit expression (Melotti and Calabretta, 1996; Ratajczak et al., 1992) but, in addition, demonstrate that Myb can transactivate the c-kit promoter in vitro. More conclusive proof of a direct eect will require mutation of the Myb binding sites in the c-kit promoter. The dierent levels of induction of the ckit promoter in ERMYB cells (200-fold) compared with that seen in CV-1 cells (12-fold) may be due to cell speci®c cooperating factors or to the levels of active Myb protein achieved in each system. c-kit is expressed on hemopoietic progenitor cells and binds stem cell factor (SCF) also known as Steel factor (SLF), which is a potent mitogen for these cells (reviewed in Galli et al., 1994) . Myb-transformed cells do not express SCF and it is unlikely, therefore, that SCF is acting as an autocrine mitogen for ERMYB cells (Macmillan and Gonda, 1994) . Rather, the regulation of the expression of c-kit by Myb may model the development of the hemopoietic system in vivo. W mutant mice which express a mutant c-Kit protein have defective hemopoiesis aecting predominantly mast cells and erythroid and myeloid lineages (reviewed in Galli et al., 1994) . Furthermore, constitutive expression of c-myb in embryonic stem cells induces c-kit expression and SCF-enhanced formation of erythromyeloid colonies (Melotti and Calabretta, 1996) . Taken together, these data support the notion that by regulating c-kit expression, Myb modulates the response of myeloid cells to the c-kit ligand during the development of hemopoietic cells in vivo. We cannot rule out, however, that c-Kit may have other as yet unknown functions which contribute to the Mybtransformed phenotype; for example, some isoforms of c-Kit exhibit a low level of ligand-independent activity (Reith et al., 1991) .
The conditionally transformed hemopoietic cells described here have provided an opportunity to examine the mechanism by which Myb transforms primary cells and allowed us to study the regulation of putative Myb target genes in myeloid cell differentiation. Our results do not support a role for c-myc or cdc2 in mediating the transforming eects of Myb. However, our results support direct regulation of c-kit expression by Myb in this system. In addition, these data con®rm that bcl-2 expression correlates with Myb activity but do not support an anti-apoptotic role for Myb in this system. The ERMYB cells should provide a valuable reagent for dissecting the function of Myb in myeloid cell proliferation and dierentiation and for the identi®cation of other Myb target genes.
Materials and methods
Plasmid construction
A retroviral vector expressing an estradiol-inducible Myb protein was constructed using the RED(CT3Myb) retroviral vector encoding a C-terminally truncated murine Myb protein (CT3Myb) (Hu et al., 1991; Sakura et al., 1989) . In order to facilitate cloning of the estrogen receptor ligand binding domain into the RED(CT3Myb) vector, a BamHI site was introduced upstream of the gag-myb junction by inserting the oligonucleotides 5'-TCGATCTTGGATC-CAGCC-/3'AGAACCTAGGTCGGAGCT into a XhoI site located 264 bp upstream of the myb coding sequence. The adaptor introduced a BamHI site and destroyed one of the XhoI sites. In order to construct a vector encoding an estrogen-inducible Myb protein [RED(ERMYB)] the estrogen binding domain of the human estrogen receptor (amino acids 282 ± 576) (Green et al., 1986) was ligated into the BamXI ± XhoI cleaved vectors. A non-hormone inducible control for use in chloramphenicol acetyltransferase (CAT) assays was constructed by inserting the viral oncogene v-myb into the pUC13 plasmid downstream of the long terminal repeat of Schmidt-Ruppin strain of Rous Sarcoma Virus (nucleotide residue 8 ± 376) (Gorman, 1985) . The reporter plasmid p8mybbCAT contains the SacI ± NcoI fragment of the plasmid pb128 (Weston and inserted 5' to the CAT gene in the CATbasic vector (Promega).
CAT assays
The dependence of ERMyb proteins on b-estradiol was assessed in Balb/c 3T3 ®broblasts grown in DMEM/10% FCS. DNA was introduced by the calcium phosphate coprecipitation method (Weber et al., 1984) . The precipitates contained 10 mg each of the eector and the reporter and 5 mg of the internal standard plasmids (SV-b-Galactosidase vector; Promega). The cells were incubated for 12 ± 14 h with precipitates, washed and fresh medium was added. Parallel dishes were treated with 10 77 M b-estradiol or the solvent ethanol. Cell extracts were prepared 48 h later and aliquots used for CAT assays. The amount of acetylated [ 3 H]chloramphenicol was determined by diusion into scintillation¯uid (Neuman et al., 1987) and the data were normalized with respect to b-galactosidase activity.
In order to determine if Myb transactivated the c-kit promoter, the CAT reporter plasmid pkit-CAT02N, in which the 8.8 kb DNA fragment containing the mouse c-kit promoter was linked to the CAT gene at the SacI site (nucleotide 728 according to the numbering system in which the A of the initiator ATG codon is +1) (Hayashi et al., 1995) . A mixture of 6 mg of pkit-CAT02N, 6 mg of the pact expression plasmid encoding either WT c-Myb, DTA Myb, DDB Myb or no protein (Sakura et al., 1989) , and 1 mg of the internal control plasmid pact-b-gal was transfected into CV-1 cells, and CAT assays were performed as described (Sakura et al., 1989) .
Transformation of hemopoietic cells with the ERMYB retrovirus
Detailed procedures for the infection of murine hemopoietic cells by retroviruses have been described elsewhere (Gonda et al., 1989a (Gonda et al., , 1993 Hu et al., 1991) . Brie¯y, viral packaging C2 cells were transfected with 10 mg RED(ERMYB) and 0.1 mg pSV2Neo vector using calcium phosphate (Gonda et al., 1989a) . Transfected cells were selected in DME/10% FCS containing 400 mg/ml G418. Murine fetal liver cells from CBA mice at 14 days of gestation were infected by co-cultivation with irradiated C2 cells (30 Gy) transfected with RED(ERMYB). Cocultivations were performed in the presence of 400 U/ml GM-CSF, 800 U/ml IL-3 and 1 mM b-estradiol.
The fetal liver cells infected with RED(ERMYB) (ERMYB cells) were washed twice in phosphate-buered saline (PBS) and resuspended in 5 ml of DMEM containing antibiotics, 16% charcoal-stripped fetal calf serum, 400 U/ml GM-CSF and 1 mM b-estradiol. Initially, the cells were cultured in the presence of a feeder layer of irradiated NIH3T3 ®broblasts, as described previously, until they were established (Macmillan and Gonda, 1994; Gonda et al., 1993) . After 8 weeks, they were maintained without feeder layers in DMEM containing antibiotics, 16% charcoalstripped fetal calf serum, 400 U/ml GM-CSF and 1 mM bestradiol.
Analysis of adherence of ERMYB cells
ERMYB cells were washed three times in PBS and resuspended in fresh medium with or without b-estradiol at a density of 2610 5 /ml. Following incubation with or without b-estradiol, non-adherent cells were decanted and the remaining adherent cells were harvested using Lidocaine (Sigma). 4 ml of 0.4% Lidocaine in DMEM was added to 75 cm 2¯a sks and the cells were incubated at 378C for 10 min. After knocking the¯asks to detach the cells, 1 ml of FCS was added and the cells were centrifuged and resuspended in DMEM/16% FCS. Viable nonadherent and adherent cells were counted by Trypan blue exclusion using a hemocytometer.
Morphological characteristics of ERMYB cells
In order to examine the aect of b-estradiol on ERMYB cells, cytospins were prepared following growth in the presence or absence of b-estradiol. 5610 3 cells were resuspended in DMEM/50% FCS and cytospun onto glass slides. Cells were dried brie¯y at room temperature, stained with May-GruÈ nwald-Giemsa stain and subjected to microscopic examination.
Esterase staining
Cells were resuspended in DMEM/50% FCS, cytospun onto slides and ®xed in esterase ®xative (2.86 mM Na 2 HPO 4 , 14.7 mM KH 2 PO 4 , 45% v/v acetone, 25% v/v formalin) for 30 s at 48C. The a-napthyl acetate substrate solution was then prepared by adding 1 ml of 10 mg/ml anapthyl acetate in acetone and 30 ml of 0.066 M phosphate buer pH 6.3 to a Coplin jar followed by 0.3 ml of 4% pararosanalin/2 M HCl which had been mixed with 0.3 ml of 4% sodium nitrite. Following three washes in distilled water, the cells were stained in the a-napthyl acetate substrate solution for 45 min at room temperature. The slides were washed three times in distilled water and stained in 20 mg of Fast Blue in 38 ml of 0.066 M phosphate buer pH 7.4 and 5 mg of napthol-AS-Dchloracetate dissolved in 2.5 ml of N-N dimethylformamide for 1 h at room temperature. Finally, the slides were washed three times in distilled water and counterstained in 2% Methyl Green. Cells expressing a-napthylacetate esterase (macrophage esterase) were identi®ed by their red-brown staining and those expressing naphthol-AS-Dacetate (neutrophil esterase) by their blue staining.
Colony formation
Colony formation was assessed by plating cells at 5000/ml in Iscove's modi®ed Dulbecco medium (IMDM) containing 1.3% methylcellulose, 10% FCS and 400 U/ml GM-CSF either with or without 1 mM b-estradiol. Colonies 430 cells and clusters 530 cells were scored following 7 and 14 days of incubation.
Analysis of surface marker expression
Analysis of cell surface antigens was performed essentially as described elsewhere (Gonda et al., 1993; and references therein) . Rat monoclonal antibodies to the surface markers Mac-1, F4/80, Thy-1.2 and Mac-3 were used to stain 10 5 ERMYB cells in a volume of 50 ml on ice for 45 min. Cells were washed twice in DME/5% FCS and incubated with uorescein-conjugated anti-rat IgG (Silenius Laboratories, Melbourne, Australia) on ice for 45 min. Cells were washed twice and analysed by¯ow cytometry using a Coulter Prolife II (Hialeah, FL).
Analysis of cellular RNA and DNA
Total cellular polyadenylated (poly(A) + ) RNA or genomic DNA was isolated from cells and analysed using Northern and Southern blotting, respectively. The procedures used for Southern and Northern blotting have been described previously (Gonda et al., 1989b) . 2 mg of poly(A) + mRNA or 10 mg of genomic DNA were analysed. Probes were 32 Plabeled using a Multiprime random priming kit (Amersham). The 5' c-myb cDNA probe consisted of the 5' (0.7 kb) EcoRI fragment of the c-myb clone, pMM49 (Gonda et al., 1985) . The human estrogen receptor probe consisted of the 0.9 kb BamHI/XhoI fragment of RED(ERMYB) comprising the ligand binding domain. The cdc2 probe was a 0.5 kb KpnI/BglII fragment derived from the coding region of human cdc2 cDNa in the plasmid pOB231 (Lee and Nurse, 1987) . The c-myc probe consisted of a 1.6 kb HindIII/SacI fragment from the murine c-myc cDNA. The c-kit probe comprised the 3 kb BamHI/BglII fragment from murine c-kit cDNA and the GAPDH probe consisted of the 0.3 kb HindIII/PstI fragment derived from murine GAPDH in the plasmid pmGAP5'. The bcl-2 probe was a 0.92 kb EcoRI ± TaqI fragment of human bcl-2 cDNA (comprising the coding sequence plus *0.19 kb 3'-untranslated sequence).
Immunoblotting
Cellular extracts were prepared from 5610 7 cells. Nonadherent cells were decanted, washed twice in PBS and collected by centrifugation. 1 ml of lysis buer (2% SDS, 10% glycerol, 0.06 M Tris pH 6.8, 0.01 M dithiothreitol, 2 mM phenylmethylsulfonyl¯uoride, 1 mg/ml leupeptin and 1 mg/ml apportioning) was added to the adherent cells in the¯ask. The lysed cells were removed by scraping and added to the non-adherent cell pellet. The cells were sonicated, boiled for 3 min and centrifuged at 45 000 r.p.m. (TLA-45 rotor; Beckman TL-100 ultracentrifuge) for 45 min at 48C. The supernatants were stored at 7708C. Cellular extracts were diluted in 1 volume of sample buer (20% glycerol, 4% SDS, 0.125 M Tris pH 6.8, 0.01% bromophenol blue and 0.7 M b-mercaptoethanol) and separated on 8% polyacrylamide/SDS gels. Proteins were transferred to nitrocellulose membrane (Schleicher and Schuell) for immunoblotting analysis. Membranes were blocked in TBS-T (50 mM Tris-HCl pH 7.4, 135 mM NaCl, 0.1% Tween 20) containing 5% skim milk. Myb proteins were detected using the 5.1 monoclonal c-Myb antibody (Ramsay et al., 1989) , horseradish peroxidase-conjugated anti-mouse IgG diluted 1/1000 (Amersham) and visualized using ECL (Amersham).
Determination of cell viability and DNA fragmentation
Cell viability was assessed by Trypan blue exclusion and microscopic examination. DNA fragmentation was determined essentially as described (RoÈ sl, 1992) by labeling cellular DNA with DNA polymerase I (Klenow fragment) and [
32 P]-dATP, followed by electrophoresis in a 1.8% agarose gel and Phosphorimager detection.
